Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pediatric Safety Tests In Juvenile Animals Need Validation, AstraZeneca Says

Executive Summary

FDA should confirm whether using juvenile animals to evaluate pediatric drug safety is more predictive of the clinical experience than current practice, AstraZeneca says in comments on a proposed agency guidance

You may also be interested in...



Preclinical Data May Support Single Study For Pediatric Cancer Drugs – Cmte.

Pediatric efficacy of oncology drugs may be shown through one clinical trial with supportive preclinical data, the Pediatric Subcommittee of FDA's Oncologic Drugs Advisory Committee suggested March 17

Preclinical Data May Support Single Study For Pediatric Cancer Drugs – Cmte.

Pediatric efficacy of oncology drugs may be shown through one clinical trial with supportive preclinical data, the Pediatric Subcommittee of FDA's Oncologic Drugs Advisory Committee suggested March 17

CDER Guidance Agenda 2004: Pregnancy, Pediatric Studies Are Priorities

FDA is planning several new guidances to refine recommendations for drug studies in children and pregnant women during 2004, the Center for Drug Evaluation & Research's guidance agenda for the coming year indicates

UsernamePublicRestriction

Register

PS041905

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel